Skip to main content
. 2023 Jun 7;137(5):1453–1461. doi: 10.1007/s00414-023-03038-6

Table 1.

Clinical characteristics of included patients

SCH (n = 10) CCH (n = 10) Control (n = 10)
Cause of death

SCD:

IHF (6), HHF (3), AS (1)

Accident (8),

Cerebral hemorrhage (2)

Accident (8),

Pneumonia (2)

Age, years 63 (41–82) 59 (43–74) 58 (42–76)
Sex 10 men 10 men 8 men, 2 women
BMI (kg/m2) 25.0 (17.5–34.5) * 25.4 (19.4–28.4) * 20.6 (14.0–27.5)
BNP (pg/mL) 30.0 (2.0–56.6) 16.4 (2.0–81.5) 6.0 (2.0–21.8)

SCD sudden cardiac death; SCH SCD with acquired cardiac hypertrophy; CCH compensated cardiac hypertrophy; IHF ischemic heart failure; HHF hypertensive heart failure; AS aortic stenosis; BMI body mass index; BNP B-type natriuretic peptide whose lowest detectable level is 2.0 pg/mL in our assay. * p < 0.05; ** p < 0.001, compared with control cases. Individual characteristics are detailed in Online Resource 1